Psychotic Disorders - Romania

  • Romania
  • Revenue in the Psychotic Disorders market is projected to reach US$35.07m in 2024.
  • Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 0.24%, resulting in a market volume of US$35.49m by 2029.
  • In global comparison, most revenue will be generated in the United States (US$2,257.00m in 2024).
  • In relation to total population figures, per person revenues of US$180.50 are generated in 2024.

Key regions: Japan, Australia, Europe, India, France

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

Psychotic disorders are a significant concern in Romania, with a growing market for treatments and therapies. Customer preferences in the country indicate a strong demand for effective and accessible treatments, while local special circumstances and underlying macroeconomic factors contribute to the development of the market.Customer preferences in Romania align with global trends in the treatment of psychotic disorders. Patients and healthcare professionals prioritize evidence-based therapies that have been proven to be effective in managing symptoms and improving quality of life. There is also a growing demand for personalized treatment plans that take into account the individual needs and preferences of patients. Accessibility and affordability are key considerations for customers, as many individuals in Romania may face financial constraints when seeking treatment options.The market for psychotic disorder treatments in Romania is experiencing several notable trends. One trend is the increasing use of psychopharmacological interventions, such as antipsychotic medications, to manage symptoms. These medications have shown efficacy in reducing hallucinations, delusions, and other symptoms associated with psychotic disorders. Additionally, there is a growing emphasis on early intervention and prevention strategies, aiming to identify and treat psychotic disorders at their earliest stages. This approach can lead to better outcomes and improved long-term prognosis for patients.Local special circumstances in Romania contribute to the development of the psychotic disorders market. The country has a well-established healthcare system, which provides access to a range of treatment options for patients. However, there are regional disparities in healthcare infrastructure and resources, which can impact the availability and accessibility of treatments in certain areas. Additionally, stigma surrounding mental health issues remains a challenge in Romania, with many individuals hesitant to seek help or disclose their condition. Efforts to reduce stigma and increase awareness of psychotic disorders are essential to ensure that individuals receive the support and treatment they need.Underlying macroeconomic factors also play a role in the development of the psychotic disorders market in Romania. The country has seen steady economic growth in recent years, which has contributed to increased healthcare spending and improved access to healthcare services. However, there are still economic challenges that may impact the affordability of treatments for some individuals. Government initiatives and policies aimed at improving access to mental healthcare services and reducing the financial burden on patients can help address these challenges and support the growth of the market.In conclusion, the psychotic disorders market in Romania is developing in response to customer preferences for effective and accessible treatments. Trends in the market include the use of evidence-based therapies and a focus on early intervention and prevention. Local special circumstances, such as regional disparities in healthcare infrastructure and stigma surrounding mental health, as well as underlying macroeconomic factors, including economic growth and healthcare spending, also contribute to the development of the market. Efforts to address these factors and improve access to treatment options are essential to support the ongoing growth of the psychotic disorders market in Romania.

Methodology

Data coverage:

Data encompasses B2C enterprises. Figures are based on companies' revenues, international institutes data, and global consumer survey data. Revenues refer to the retail value and include sales taxes.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use financial reports and third-party data. Next, we use relevant key market indicators and data from country-specific associations such as healthcare spending per capita, medical product spending per capita, and gross domestic product per capita. This data helps us to estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, S-Curve function, ARIMA time series model and exponential curve function. Data is modeled using current exchange rates.

Additional Notes:

The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. GCS data is reweighted for representativeness.

Overview

  • Revenue
  • Patients
  • Analyst Opinion
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)